TCL Archive ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication February 17, 2012
TCL Archive John Niederhuber named NCI chief operating officer; the surgeon was asked to leave two previous positions. October 7, 2005
TCL Archive New Test Predicts Breast Cancer Recurrence And Who Benefits Most From Chemotherapy December 31, 2004